Leveraging progress in prevention of mother-to-child transmission of HIV for improved maternal, neonatal, and child health services

J Acquir Immune Defic Syndr. 2011 Aug;57 Suppl 2:S83-6. doi: 10.1097/QAI.0b013e31821e9477.

Abstract

Finding ways to leverage the substantial investment in prevention of mother-to-child transmission of HIV to address other maternal, neonatal, and child health threats is a priority. With increased emphasis on health systems strengthening and the integration of disease-specific initiatives within primary care, we propose three areas for consideration: 1) increased integration of service delivery; 2) adaptation of successful implementation models; and 3) a reconceptualization of the care continuums for prevention of mother-to-child HIV transmission and maternal, neonatal, and child health.

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Child
  • Child Health Services / economics*
  • Child Health Services / organization & administration
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / economics
  • HIV Infections / prevention & control*
  • HIV Infections / transmission*
  • Health Services Needs and Demand / economics
  • Health Services Needs and Demand / organization & administration*
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / economics
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Infectious Disease Transmission, Vertical / statistics & numerical data
  • Maternal Health Services / economics
  • Maternal Health Services / organization & administration*
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy
  • Pregnancy Complications, Infectious / prevention & control*
  • Primary Health Care / economics
  • Primary Health Care / organization & administration*
  • Primary Health Care / statistics & numerical data

Substances

  • Anti-HIV Agents